Early research (Phase 1)Ended earlyNCT03333694
What this trial is testing
Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis)
Who this might be right for
Cutaneous Squamous Cell Carcinoma in Situ (CSCCis)
Novartis Pharmaceuticals 40